Inluriyo
NDC 0002-1717, imlunestrant, tablet, film coated, from Eli Lilly and Company.
- Product NDC
- 0002-1717
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA218881
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0002-1717 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IMLUNESTRANT200 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-1717-28 | 00002171728 | 28 TABLET, FILM COATED in 1 BOTTLE (0002-1717-28) |
| 0002-1717-56 | 00002171756 | 56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-56) |
| 0002-1717-61 | 00002171761 | 56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-61) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5bc172e4-e8a2-441a-be52-279a7f890196
Use it
Look up 0002-1717 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-1717 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-1717. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.